2024 Germany Hospital Tumor Marker Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Competitive Analysis, Emerging Opportunities

This new report contains 530 pages, 40 tables, is available by section, and can be customized to specific information needs and budget.

The report presents a comprehensive analysis of the German hospital tumor marker testing market, including:  

  • Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. 
  • Test volume and sales forecasts for 40 tumor markers performed in German hospitals. 
  • Current instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of leading suppliers. 
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for suppliers.


    Introduction
    Worldwide Market and Technology Overview
    A. Cancer Statistics and Etiology
    1. Brest Cancer
    2. Lung Cancer
    3. Colon and Rectum Cancer
    4. Prostate Cancer
    5. Stomach Cancer
    6. Leukemia
    7. Lymphoma
    8. Oral Cancer
    9. Skin Cancer
    10. Uterine Cancer
    11. Ovarian Cancer
    12. Bladder Cancer
    B. Major Current And Emerging Cancer Diagnostic Tests
    1. Introduction
    2. Tumor Marker Classification
    3. ACTH
    4. Alpha-Fetoprotein (AFP)
    5. Beta-2 Microglobulin
    6. CA 15-3/27.29
    7. CA 19-9
    8. CA-125
    9. Calcitonin
    10. Carcinoembrionic Antigen (CEA)
    11. Estrogen and Progesterone Receptors
    12. Ferritin
    13. Gastrin
    14. Human Chorionic Gonadotropin (HCG)
    15. Insulin

    16. NSE
    17. Occult Blood
    18. PAP Smear/HPV
    19. Prostatic Acid Phosphatase (PAP)
    20. Prostate-Specific Antigen (PSA)
    21. Squamous Cell Carcinoma Antigen (SCC)
    22. T and B Lymphocytes
    23. TdT
    24. Thyroglobulin
    25. Tissue Polypeptide Antigen (TPA)
    26. Biochemical Tumor Markers
    - ADA
    - B-Protein
    - PNP
    - 5-Nucleotidase
    27. Oncogenes
    - Abl/abl-bcr
    - AIB1
    - BCL-2
    - BRCA1
    - CD44
    - C-fos
    - C-myb
    - C-myc
    - CYP-17
    - Erb-B
    - HPC1
    - N-myc
    - P40
    - P51
    - P53
    - PIK3CA
    - PTI-1
    - Ras
    - Reg
    - Sis
    - Src

    28. Polypeptide Growth Factors
    - Basic Fibroblast Growth Factor
    - Beta-TGF
    - Cachectin (TNT)
    - Calmodulin
    - ECFR
    - Nerve Growth Factor (NGF)
    - Epidermal Growth Factor (EGF)
    - Ornithine Decarboxylase
    - Transferrin
    - Transforming Growth Factor-Alpha
    29. Ectopic Hormones
    30. Colony Stimulating Factors
    31. Lymphokines
    - Alpha-Interferon
    - B Cell Growth Factors
    - B Cell Growth Factor (BCGF)
    - Gamma-Interferon
    - Interleukin-1 (IL-1)
    - Macrophage Activating Factor
    32. Immunohistochemical Stains
    33. Emerging Tumor Markers
    - N-Acetylglucosamine
    - Actin
    - Alpha-Actin
    - Antineuronal Antibodies
    - 7B2
    - B72.3
    - Bax
    - BCD-F9
    - BLCA-4
    - Blood Group Antigens A,B,H
    - CA 50
    - CA 72-4/TAG-72
    - CA 195
    - CA-242
    - CA-549
    - CAM 26
    - CAR-3

    - Cathepsin-D
    - Chromogranin A and B
    - Cluster 1 Antigen
    - Cluster-5/5A Antigen
    - CTA
    - CU18
    - DR-70
    - DU-PAN-2
    - Endometrial Bleeding Associated Factor
    - Endostatin
    - Epithelial Membrane Antigen
    - Feulgen Hydrolysis
    - Fibronectin
    - FSH
    - (1->3)-L-fucosyltransferase
    - Gastrin-Releasing Peptide (GRP)
    - GDCFP-15
    - Glucagon
    - Glycoamines
    - H23
    - Her-2
    - Human Carcinoma Antigen
    - HPA
    - HSP27
    - Intermediate Filaments
    - Cytokeratins/CK18/Cyfra 21-1
    - Desmin
    - Gliofibrillary Acid Protein
    - Neurofilaments
    - Vimentin
    - KA 93
    - Kinases
    - KP16D3
    - LAI
    - Leukocyte Common Antigen
    - Lewis Antigens
    - Lysophosphatidic Acid (LPA)
    - Ma 695/Ma 552
    - MABDF3
    - MAG
    - ME1

    - Minactivin
    - MN/CA9
    - MSA
    - Mucin Cancer Antigen (MCA)
    - Multiple Tumor Suppressor 1
    - Myosin
    - NEA-130
    - NMP22
    - OA-519
    - Opiod Peptides
    - P-glycoprotein
    - Pancreatic Oncofetal Antigen (POA)
    - Placental Lactogen
    - PR92
    - Proliferative Index, Ki-67
    - Px
    - RB Inactivation/Deletion
    - Ret
    - SCCL 175
    - Selectin
    - Sialic Acid
    - Sialyl SSEA-1/SLX
    - SN10
    - Somatostatin
    - TA-90
    - TABA
    - Tachykinin
    - TAG 12
    - TPS
    - Troponin
    - Tubulin
    - VCAM
    - VEGF
    - Villen
    C. Instrumentation Review And
    Market Needs
    1. Abbott AxSYM
    2. Abbott Architect c4000
    3. Abbott Architect i2000 Series
    4. Abbott Architect ci8200 System

    5. Beckman Coulter UniCel Series
    6. Beckman Coulter Access
    7. Binding Site ESP600
    8. bioMerieux Mini Vidas
    9. Carolina Chemistries BioLis 24i
    10. DiaSorin Liaison
    11. Horiba ABX Pentra 400
    12. Inverness DS2
    13. J&J Vitros ECi/ECiQ
    14. J&J Vitros 3600
    15. J&J Vitros 5600
    16. Olympus AU5400
    17. Olympus AU3000i
    18. Olympus AU2700
    19. Roche Modular Analytics
    20. Roche Cobas Integra 400
    21. Roche Cobas Integra 400 Plus
    22. Roche Elecsys
    23. Roche Cobas c311
    24. Siemens ADVIA Centaur
    25. Siemens Dimension
    26. Siemens Dimension RxL Max
    27. Siemens Dimension Vista 500
    28. Siemens Immulite
    29. Siemens Stratus
    30. Tosoh AIA-Series
    31. Vital Diagnostics ATAC 8000
    32. Vital Diagnostics Envoy 500
    D. Current and Emerging Technologies
    1. Monoclonal and Polyclonal Antibodies
    2. Immunoassays
    a. Technological Principle
    b. Radioimmunoassay (RIA)
    c. Enzyme Immunoassays (EIA)
    - Overview
    - ELISA
    - Immunofiltration
    - Particle-Membrane Capture Immunoassay
    - Enzyme Amplification

    d. Fluorescent Immunoassays
    e. Luminescence
    - Chemiluminescence
    - Bioluminescence
    f. Latex Agglutination
    g. Immunoprecipitation
    h. Affinity Chromatographu
    i. Liposome Flow-Injection Immunoassay
    3. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
    - PCR
    - DAP-PCR
    - Immuno-PCR
    - QC-PCR
    - CAR
    - DNA
    - HPA
    - LCR
    - NASBA
    - QBR
    - SDA
    - 3 SR, and others
    4. Chromosome Analysis
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas
    Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
    5. Artificial Intelligence
    6. Flow Cytometry
    7. Two Dimensional Gel Electrophoresis (2-DGE)
    8. Biosensors
    9. Competing/Complementing Technologies
    a. CT
    b. MRI

    c. NMR
    d. PET
    e. Photonics Spectroscopy
    E. Personal Testing
    Country
    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers
    Major Product Development Opportunities
    A. Reagent Kits and Test Systems/Panels
    B. Instrumentation
    C. Computers, Software and Automation
    D. Auxiliary Products
    Design Criteria for Decentralized Testing Products
    Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies
    1. Marketing Approaches
    2. Product Complexity
    3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types of Distributors
    7. Market Segmentation Factor
    Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition

    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Competitive Profiles
    - Abbott
    - Affymetrix
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - bioMerieux
    - Bio-Rad
    - Cepheid
    - Diamedix
    - DiaSorin
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Fujirebio
    - Grifols
    - GSK Biologicals
    - Hologic
    - Leica Biosystems
    - Lonza
    - Ortho-Clinical Diagnostics
    - PerkinElmer
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - SeraCare
    - Siemens Healthineers
    - Takara Bio
    - Thermo Fisher
    - Wako
    Appendixes
    Appendix I: Major Universities and Research Centers
    Developing Cancer Diagnostic Technology and
    Applications
    Appendix II: Assumed Currency Exchange Rates

    Global Vitamin D Market Research Report 2020-2024

    In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Vitamin D Report by Material, Application, and Geography Global Forecast

    USD 2850 View Report

    2020 What’s Driving the Healthcare Industry?--The Road to 2024 and Beyond

    The series includes current assessments of more than 1,000 companies worldwide. Depending on the companys business nature and structure, the assessments include all or some of the following analyses: Organization

    USD 4500 View Report

    2021 Germany Hospital Infectious Disease Market Shares, Segmentation Forecasts, Emerging Opportunities and Growth Strategies for Suppliers

    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and

    USD 3500 View Report

    2024 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares and Strategie--Blood Banks, Hospitals, Commercial Labs--Emerging Technologies, Latest Instrumentation, Competitive Analysis

    This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German molecular blood banking market during the next five years,

    USD 3500 View Report

    Fill The Form For Sample Request

    Note : * Kindly provide us with your company id and get the sample reports at the earliest.

    There is no Reviews available